Cargando…

COVID-19 Vaccine Hesitancy among Behavioral Risk Takers

The COVID-19 pandemic has emerged as a major public health issue, with vaccines serving as a vital preventive strategy to lower the global burden. Yet, despite national and local mandates, key sectors of the population continue to demonstrate lower compliance rates. In the United States, young adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Becerra, Monideepa B., Becerra, Benjamin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144473/
https://www.ncbi.nlm.nih.gov/pubmed/35632523
http://dx.doi.org/10.3390/vaccines10050767
_version_ 1784716056753864704
author Becerra, Monideepa B.
Becerra, Benjamin J.
author_facet Becerra, Monideepa B.
Becerra, Benjamin J.
author_sort Becerra, Monideepa B.
collection PubMed
description The COVID-19 pandemic has emerged as a major public health issue, with vaccines serving as a vital preventive strategy to lower the global burden. Yet, despite national and local mandates, key sectors of the population continue to demonstrate lower compliance rates. In the United States, young adults have the lowest vaccination rates among the adult population. The goal of our study was to utilize the largest state-health survey to assess the key determinants of such hesitancy in order to create targeted interventions for the most at-risk groups to ensure equitable outcomes in disease prevention. We utilized the latest available California Health Interview Survey, a population-based complex probability survey, to evaluate determinants of vaccine hesitancy among young adults. Survey-weighted descriptive statistics, bivariate statistics, and multivariable logistic regression analyses were conducted. All statistical tests used p less than 0.05 to determine statistical significance. A total of 1203 respondents, representative of 4,027,462 young adults (ages 18–25 years) were included in our study. Our primary findings note that 24% of participants reported they would not be willing to take the COVID-19 vaccination. Prevalence of vaccine hesitancy was also significantly higher among young adults who were current smokers (including electronic cigarettes), when compared to non-current smokers (36% vs. 22%). Further, the highest prevalence was also noted among young adults who identified as African-American (51%), had a high school degree or less (34%), those who were overweight or obese (28%), and reported a poor health status (22%). Multivariable regression analysis demonstrated that current smokers, as compared to non-current smokers, had more than double the odds of reporting COVID-19 vaccine hesitancy. African-American young adults or young adults with a high school degree or less were both independently associated with at least a three-fold increase in vaccine hesitancy. Participants with psychological distress, however, were more likely to be accepting of the vaccine. Public health efforts to improve vaccine compliance need targeted efforts, including building trust in the healthcare system for African-Americans and promoting easier access and knowledge of vaccines among those with a high school degree or less, as well as young-adults who are currently smoking, with such efforts targeting behavioral interventions focused on risk aversion.
format Online
Article
Text
id pubmed-9144473
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91444732022-05-29 COVID-19 Vaccine Hesitancy among Behavioral Risk Takers Becerra, Monideepa B. Becerra, Benjamin J. Vaccines (Basel) Article The COVID-19 pandemic has emerged as a major public health issue, with vaccines serving as a vital preventive strategy to lower the global burden. Yet, despite national and local mandates, key sectors of the population continue to demonstrate lower compliance rates. In the United States, young adults have the lowest vaccination rates among the adult population. The goal of our study was to utilize the largest state-health survey to assess the key determinants of such hesitancy in order to create targeted interventions for the most at-risk groups to ensure equitable outcomes in disease prevention. We utilized the latest available California Health Interview Survey, a population-based complex probability survey, to evaluate determinants of vaccine hesitancy among young adults. Survey-weighted descriptive statistics, bivariate statistics, and multivariable logistic regression analyses were conducted. All statistical tests used p less than 0.05 to determine statistical significance. A total of 1203 respondents, representative of 4,027,462 young adults (ages 18–25 years) were included in our study. Our primary findings note that 24% of participants reported they would not be willing to take the COVID-19 vaccination. Prevalence of vaccine hesitancy was also significantly higher among young adults who were current smokers (including electronic cigarettes), when compared to non-current smokers (36% vs. 22%). Further, the highest prevalence was also noted among young adults who identified as African-American (51%), had a high school degree or less (34%), those who were overweight or obese (28%), and reported a poor health status (22%). Multivariable regression analysis demonstrated that current smokers, as compared to non-current smokers, had more than double the odds of reporting COVID-19 vaccine hesitancy. African-American young adults or young adults with a high school degree or less were both independently associated with at least a three-fold increase in vaccine hesitancy. Participants with psychological distress, however, were more likely to be accepting of the vaccine. Public health efforts to improve vaccine compliance need targeted efforts, including building trust in the healthcare system for African-Americans and promoting easier access and knowledge of vaccines among those with a high school degree or less, as well as young-adults who are currently smoking, with such efforts targeting behavioral interventions focused on risk aversion. MDPI 2022-05-12 /pmc/articles/PMC9144473/ /pubmed/35632523 http://dx.doi.org/10.3390/vaccines10050767 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Becerra, Monideepa B.
Becerra, Benjamin J.
COVID-19 Vaccine Hesitancy among Behavioral Risk Takers
title COVID-19 Vaccine Hesitancy among Behavioral Risk Takers
title_full COVID-19 Vaccine Hesitancy among Behavioral Risk Takers
title_fullStr COVID-19 Vaccine Hesitancy among Behavioral Risk Takers
title_full_unstemmed COVID-19 Vaccine Hesitancy among Behavioral Risk Takers
title_short COVID-19 Vaccine Hesitancy among Behavioral Risk Takers
title_sort covid-19 vaccine hesitancy among behavioral risk takers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144473/
https://www.ncbi.nlm.nih.gov/pubmed/35632523
http://dx.doi.org/10.3390/vaccines10050767
work_keys_str_mv AT becerramonideepab covid19vaccinehesitancyamongbehavioralrisktakers
AT becerrabenjaminj covid19vaccinehesitancyamongbehavioralrisktakers